The latest news for pharma industry insiders.
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Findings from two recent surveys found that U.S. healthcare consumers lack much of their confidence in affordability and access to healthcare, as well as patient safety.
An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.
PerkinElmer announced the acquisition of Project Farma, a subsidiary of Precision for Medicine. Project Farma is a leading life sciences consultancy focused on advancing technical operations from ideation through commercialization, offering project management, project controls, commissioning, qualification and validation, quality compliance and engineering consulting services. Terms of the acquisition were not disclosed.
Check out my extended conversation with Pleio CCO, Jennifer Butler on this week's episode of the
Have news you want us to share in Pharma Pulse? Reach out to Editor
